In addition to nuclear and climate risks, the scientists warned of potential misuse of biotechnology and artificial ...

The Bulletin of the Atomic Scientists cites nuclear threats, climate change, and technological risks exacerbated by weakened ...

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

The Natural History Museum, London and Earlham Institute, Norwich today announce a joint venture spin-out company Agnos Biosciences™ (the first of its kind in the Museum’s history). The Agnos ...

2026 could be a pivotal year for three biotech names, including a standout in the hemodialysis space and two emerging ...

The Bulletin of the Atomic Scientists cited risks of nuclear war, climate change, potential misuse of biotechnology and the ...

A North Carolina startup is working to change that. DwellSafe, whose team works out of Asheville and New York City, has ...

On December 24, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that healthcare has become the top-performing sector over the last 3 ...

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic ...

According to ArkeoNews, the structure was built during a flourishing period of Roman expansion when thermal baths served not merely as places for hygiene, but as centers of healing and social ...

Booth said timing drove sharply different investor outcomes in Ventyx. ・Clear Street said Lilly was a logical buyer and cut Ventyx to ‘Hold’. ・LifeSci Capital said the stock reset to ‘Market Perform’ ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...